{
  "directed": true,
  "graph": {
    "annotation_list": {
      "AssayType": [
        "B"
      ],
      "MeasurementRelation": [
        "="
      ],
      "MeasurementType": [
        "Ki"
      ],
      "MeasurementUnits": [
        "nM"
      ],
      "MeasurementValue": [
        "1.3",
        "1.4",
        "1.9"
      ]
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Kristian Kolpeja",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2018 Fraunhofer Institute SCAI, All rights reserved",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "In Vivo and In Vitro Characterization of Antalarmin, a Nonpeptide Corticotropin-Releasing Hormone (CRH) Receptor Antagonist: Suppression of Pituitary ACTH Release and Peripheral Inflammation",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "CL": "^\\d{7}$",
      "DBSNP": "rs[0-9]+"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"
    },
    "path": "antalarmin/lewis1996.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Anatomy": {
          "hypothalamus": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "db": "PubMed",
        "db_id": "8940412",
        "db_name": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "first": "Webster EL",
        "journal": "Endocrinology",
        "last": "Chrousos GP",
        "pages": "5747-50",
        "volume": "137"
      },
      "evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
      "key": "72d60372cb1f5334a2f7c01ce4712090",
      "line": 81,
      "relation": "regulates",
      "source": 4,
      "subject": {
        "modifier": "Activity"
      },
      "target": 1
    },
    {
      "annotations": {
        "Anatomy": {
          "hypothalamus": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "db": "PubMed",
        "db_id": "8940412",
        "db_name": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "first": "Webster EL",
        "journal": "Endocrinology",
        "last": "Chrousos GP",
        "pages": "5747-50",
        "volume": "137"
      },
      "evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
      "key": "2bfd691864d23c236dbde4b43af4b8b6",
      "line": 82,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 4,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "Anatomy": {
          "hypothalamus": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "db": "PubMed",
        "db_id": "8940412",
        "db_name": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "first": "Webster EL",
        "journal": "Endocrinology",
        "last": "Chrousos GP",
        "pages": "5747-50",
        "volume": "137"
      },
      "evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
      "key": "1e7a1c3d47972f7733f8408e2c80bcaa",
      "line": 83,
      "relation": "positiveCorrelation",
      "source": 4,
      "subject": {
        "modifier": "Activity"
      },
      "target": 3
    },
    {
      "annotations": {
        "Anatomy": {
          "pituitary gland": true
        },
        "AssayType": {
          "B": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "Ki": true
        },
        "MeasurementUnits": {
          "nM": true
        },
        "MeasurementValue": {
          "1.9": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "db": "PubMed",
        "db_id": "8940412",
        "db_name": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "first": "Webster EL",
        "journal": "Endocrinology",
        "last": "Chrousos GP",
        "pages": "5747-50",
        "volume": "137"
      },
      "evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
      "key": "98785b2ef96a69454407007af1d74c20",
      "line": 99,
      "object": {
        "modifier": "Activity"
      },
      "relation": "directlyIncreases",
      "source": 4,
      "subject": {
        "modifier": "Activity"
      },
      "target": 5
    },
    {
      "annotations": {
        "Anatomy": {
          "hypothalamus": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "db": "PubMed",
        "db_id": "8940412",
        "db_name": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "first": "Webster EL",
        "journal": "Endocrinology",
        "last": "Chrousos GP",
        "pages": "5747-50",
        "volume": "137"
      },
      "evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
      "key": "dc8eaadf2483cd060c6149961bfd023a",
      "line": 83,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 3,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "db": "PubMed",
        "db_id": "8940412",
        "db_name": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "first": "Webster EL",
        "journal": "Endocrinology",
        "last": "Chrousos GP",
        "pages": "5747-50",
        "volume": "137"
      },
      "evidence": "These results raise the possibility that pyrrolopyrimidine compounds, such as antalarmin, which antagonize CRH at the level of its own receptor, have therapeutic potential in some forms of inflammation.",
      "key": "77327690081781a611e6f7f82cc1af5a",
      "line": 128,
      "relation": "negativeCorrelation",
      "source": 3,
      "target": 0
    },
    {
      "annotations": {
        "Anatomy": {
          "pituitary gland": true
        },
        "AssayType": {
          "B": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "Ki": true
        },
        "MeasurementUnits": {
          "nM": true
        },
        "MeasurementValue": {
          "1.9": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "db": "PubMed",
        "db_id": "8940412",
        "db_name": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "first": "Webster EL",
        "journal": "Endocrinology",
        "last": "Chrousos GP",
        "pages": "5747-50",
        "volume": "137"
      },
      "evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
      "key": "4465728d59a3e5630b061625739de9cb",
      "line": 98,
      "object": {
        "modifier": "Activity"
      },
      "relation": "directlyDecreases",
      "source": 0,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "db": "PubMed",
        "db_id": "8940412",
        "db_name": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "first": "Webster EL",
        "journal": "Endocrinology",
        "last": "Chrousos GP",
        "pages": "5747-50",
        "volume": "137"
      },
      "evidence": "Indeed, the compound significantly suppressed (XI-l-induced ACTH secretion to approximately the same extent as neutralizing polyclonal anti-CRH.",
      "key": "49cc4bead8a79f776c14107405a33ee9",
      "line": 135,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 0,
      "target": 4
    },
    {
      "annotations": {
        "Anatomy": {
          "pituitary gland": true
        },
        "AssayType": {
          "B": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "Ki": true
        },
        "MeasurementUnits": {
          "nM": true
        },
        "MeasurementValue": {
          "1.9": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "db": "PubMed",
        "db_id": "8940412",
        "db_name": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "first": "Webster EL",
        "journal": "Endocrinology",
        "last": "Chrousos GP",
        "pages": "5747-50",
        "volume": "137"
      },
      "evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
      "key": "83f6670c7e589e828f4111b4345e61cc",
      "line": 100,
      "object": {
        "modifier": "Activity"
      },
      "relation": "directlyDecreases",
      "source": 0,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "db": "PubMed",
        "db_id": "8940412",
        "db_name": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "first": "Webster EL",
        "journal": "Endocrinology",
        "last": "Chrousos GP",
        "pages": "5747-50",
        "volume": "137"
      },
      "evidence": "These results raise the possibility that pyrrolopyrimidine compounds, such as antalarmin, which antagonize CRH at the level of its own receptor, have therapeutic potential in some forms of inflammation.",
      "key": "cfcbc94b287f1698a77f66b654e3273e",
      "line": 128,
      "relation": "negativeCorrelation",
      "source": 0,
      "target": 3
    },
    {
      "annotations": {
        "Anatomy": {
          "frontal cortex": true
        },
        "AssayType": {
          "B": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "Ki": true
        },
        "MeasurementUnits": {
          "nM": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "db": "PubMed",
        "db_id": "8940412",
        "db_name": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "first": "Webster EL",
        "journal": "Endocrinology",
        "last": "Chrousos GP",
        "pages": "5747-50",
        "volume": "137"
      },
      "evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
      "key": "ec100ba399321a3e12d6ee8d02b2f739",
      "line": 116,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 6,
      "subject": {
        "modifier": "Activity"
      },
      "target": 5
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:antalarmin)",
      "concept": {
        "name": "antalarmin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ec0bad83f1cd617920098f14e476f09a"
    },
    {
      "bel": "a(MESH:\"Adrenocorticotropic Hormone\")",
      "concept": {
        "name": "Adrenocorticotropic Hormone",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "b809fde658447df52e1cb116e0c095e4"
    },
    {
      "bel": "a(MESH:Glucocorticoids)",
      "concept": {
        "name": "Glucocorticoids",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f9bcc0ddc6d566c52744396122b75669"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "concept": {
        "name": "inflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "abd32f6c5cca606061975532840db260"
    },
    {
      "bel": "p(RGD:Crh)",
      "concept": {
        "name": "Crh",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "f836453b1f32331adc27a9653bc73809"
    },
    {
      "bel": "p(RGD:Crhr1)",
      "concept": {
        "name": "Crhr1",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "022aaa7a5769b701d4544144254c1e31"
    },
    {
      "bel": "p(RGD:Crhr2)",
      "concept": {
        "name": "Crhr2",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "44ff501d658929e0600cae569d85616e"
    }
  ]
}